185 related articles for article (PubMed ID: 32775353)
21. Does the visceral fat tissue show better correlation with the fatty replacement of the pancreas than with BMI?
Ozbulbul NI; Yurdakul M; Tola M
Eurasian J Med; 2010 Apr; 42(1):24-7. PubMed ID: 25610114
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma.
Korpela T; Ristimäki A; Udd M; Vuorela T; Mustonen H; Haglund C; Kylänpää L; Seppänen H
BMC Cancer; 2022 Jan; 22(1):23. PubMed ID: 34980011
[TBL] [Abstract][Full Text] [Related]
23. Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study.
Miura S; Takikawa T; Kikuta K; Hamada S; Kume K; Yoshida N; Tanaka Y; Matsumoto R; Ikeda M; Kataoka F; Sasaki A; Hatta W; Inoue J; Masamune A
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574034
[TBL] [Abstract][Full Text] [Related]
24. Lack of Independent Association Between Fatty Pancreas and Incidence of Type 2 Diabetes: 5-Year Japanese Cohort Study.
Yamazaki H; Tsuboya T; Katanuma A; Kodama Y; Tauchi S; Dohke M; Maguchi H
Diabetes Care; 2016 Oct; 39(10):1677-83. PubMed ID: 27422578
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma.
Li HB; Wang JL; Jin XD; Zhao L; Ye HL; Kuang YB; Ma Y; Jiang XY; Yu ZY
BMC Cancer; 2021 Sep; 21(1):1039. PubMed ID: 34530774
[TBL] [Abstract][Full Text] [Related]
26. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".
Matsuda R; Miyasaka Y; Yamada Y; Kawata J; Sakihama K; Yamamoto T; Saeki K; Yamamoto H; Ohishi Y; Koga Y; Nakamura M; Oda Y
Virchows Arch; 2020 Dec; 477(6):799-806. PubMed ID: 32468246
[TBL] [Abstract][Full Text] [Related]
27. Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population.
Liao W; Clift AK; Patone M; Coupland C; González-Izquierdo A; Pereira SP; Hippisley-Cox J
Br J Gen Pract; 2021 Nov; 71(712):e836-e845. PubMed ID: 34544691
[TBL] [Abstract][Full Text] [Related]
28. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
29. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
[TBL] [Abstract][Full Text] [Related]
30. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
31. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
32. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
[TBL] [Abstract][Full Text] [Related]
33. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Busek P; Vanickova Z; Hrabal P; Brabec M; Fric P; Zavoral M; Skrha J; Kmochova K; Laclav M; Bunganic B; Augustyns K; Van Der Veken P; Sedo A
Pancreatology; 2016; 16(5):829-38. PubMed ID: 27320722
[TBL] [Abstract][Full Text] [Related]
34. Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma.
Nagayama Y; Tanoue S; Inoue T; Oda S; Nakaura T; Utsunomiya D; Yamashita Y
Eur Radiol; 2020 Jan; 30(1):394-403. PubMed ID: 31312889
[TBL] [Abstract][Full Text] [Related]
35. Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis.
Vujasinovic M; Dugic A; Maisonneuve P; Aljic A; Berggren R; Panic N; Valente R; Pozzi Mucelli R; Waldthaler A; Ghorbani P; Kordes M; Hagström H; Löhr JM
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33228173
[No Abstract] [Full Text] [Related]
36. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
Yin JB; Li N; Cui MM; Wang X; Wang RT
BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound Time-Harmonic Elastography of the Pancreas: Reference Values and Clinical Feasibility.
Burkhardt C; Tzschätzsch H; Schmuck R; Bahra M; Jürgensen C; Pelzer U; Hamm B; Braun J; Sack I; Marticorena Garcia SR
Invest Radiol; 2020 May; 55(5):270-276. PubMed ID: 31985600
[TBL] [Abstract][Full Text] [Related]
39. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
40.
Su W; Zhao S; Chen Y; Zuo C; Cui B; Wang M; Ren F
Abdom Radiol (NY); 2020 Mar; 45(3):743-749. PubMed ID: 31907569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
